MDGL

Madrigal Pharmaceuticals Inc.

Price

$495.49

return (12m)

11.85%

p/e

-44.42

p/bv

27.57

DIVIDEND YIELD

0.00%

MDGL price

Madrigal Pharmaceuticals

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment MDGL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-9.22%

3 months

-5.85%

1 year

11.85%

2 years

139.85%

5 years

530.23%

10 years

2,941.68%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals MDGL

Valuation

P/E

-44.42

Sector -3.46

Industry -3.46

P/BV

27.57

Sector 1.94

Industry 1.94

P/Revenue (PSR)

11.25

Sector 1.96

Industry 1.96

EV/EBITDA

-281.01

Sector -216.42

Industry -216.42

EV/EBIT

-278.87

Sector -46.11

Industry -46.11

P/EBITDA

-49.44

Sector -21.02

Industry -21.02

P/EBIT

-49.19

Sector -27.60

Industry -27.60

P/Total Assets

11.60

Sector 1.14

Industry 1.14

P/Net Current Assets

30.20

Sector -10.24

Industry -10.24

P/Working Capital

17.50

Sector -162.19

Industry -162.19

EPS

-11.15

Sector -1.78

Industry -1.78

BVPS

17.97

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

91.48%

Sector 41.35%

Industry 41.35%

EBITDA Margin

-13.62%

Sector -17,192.92%

Industry -17,192.92%

EBIT Margin

-13.73%

Sector -4,203,320.32%

Industry -4,203,320.32%

Operating Margin

-25.13%

Sector -35.47%

Industry -35.47%

Net Profit Margins

-25.32%

Sector -35.90%

Industry -35.90%

Asset Turnover

0.29

Sector 0.03

Industry 0.03

Profitability

ROE

-62.07%

Sector -57.40%

Industry -57.40%

ROA

-26.12%

Sector -59.43%

Industry -59.43%

ROIC

-219.80%

Sector -2,370.21%

Industry -2,370.21%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.20

Sector 2.91

Industry 2.91

Net Debt / EBITDA

10.04

Sector -21.98

Industry -21.98

Net Debt / EBIT

9.96

Sector -8.44

Industry -8.44

Net Debt / Equity

-0.95

Sector -33,112.99

Industry -33,112.99

Gross Debt / Equity

0.65

Sector -0.85

Industry -0.85

Equity/Assets

0.42

Sector 0.46

Industry 0.46

Liabilities/Assets

0.58

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

6.09%

Sector -

Industry -

Fundamentals MDGL

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
MDGL Madrigal Pharmaceuticals Inc.	$495.49	10.32%	0.00%	-44.42	27.57	-62.07%	-25.32%
PFE Pfizer Inc.	$27.48	8.11%	6.26%	36.14	1.83	5.07%	6.80%
ABBV AbbVie Inc.	$259.97	9.77%	2.63%	72.88	-77.57	-106.44%	9.81%
NVO Novo Nordisk A/S	$37.23	-33.47%	4.98%	9.10	4.83	53.11%	35.32%
MRK Merck & Co. Inc.	$143.18	65.09%	2.36%	110.80	8.37	7.56%	4.77%
AZN AstraZeneca PLC	$156.59	-4.79%	2.06%	18.71	4.82	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$60.33	34.59%	4.20%	13.14	5.46	41.59%	18.87%
ZTS Zoetis Inc.	$69.46	-51.82%	3.01%	11.00	9.21	83.77%	27.69%
AMGN Amgen Inc.	$402.15	38.44%	2.47%	24.84	18.58	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$729.88	22.13%	0.51%	17.33	2.37	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$108.98	45.42%	0.00%	30.90	89.03	288.13%	24.86%
MCK McKesson Corporation	$888.29	16.56%	0.38%	22.96	-27.29	-118.84%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$501.27	24.01%	0.00%	28.87	6.28	21.76%	35.00%
CAH Cardinal Health Inc.	$226.17	45.05%	0.91%	30.94	-19.47	-62.92%	0.67%
ARGX argenx SE	$914.13	19.13%	0.00%	20.47	5.36	26.20%	25.70%
HRMY Harmony Biosciences Holdings Inc.	$39.41	46.40%	0.00%	12.60	2.28	18.14%	18.88%
BIIB Biogen Inc.	$220.34	42.87%	0.00%	38.99	1.73	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

MDGL - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Madrigal Pharmaceuticals

Madrigal Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

15 years

Founded: 2011

2007

Time since IPO - 19 years

42

Employees

Madrigal Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $14.44 billion, with shareholders equity totaling $523.72 million.

The company employs approximately 42 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Madrigal Pharmaceuticals Inc. reported $1.28 billion in revenue, generating net income of $-325.10 million.

Key financial metrics include a P/E ratio of -44.42, a price-to-book (P/B) ratio of 27.57, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker MDGL.

Market cap

$14.44 billion

Net worth

$523.72 million

$523,724,000.00

Assets

$1.24 billion

$1,244,645,000.00

Total Shares Outstanding

29.15 million

29,145,000

Average Daily Trading Volume

$290.64 Thousand

$290,642.46

Sector

Health Care

Industry

Biotechnology

MDGL

MDGL revenue and profits

Financial Results MDGL

DRAG THE FRAME TO SEE MORE DATA

MDGL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$888.29 20,83% (12M)

P/E

22.96

0.38%

ROE

-118.84%

P/BV

-27.29

CAH - Cardinal Health

$226.17 47,96% (12M)

P/E

30.94

0.91%

ROE

-62.92%

P/BV

-19.47

ABBV - AbbVie

$259.97 14,69% (12M)

P/E

72.88

2.63%

ROE

-106.44%

P/BV

-77.57

MRK - Merck & Co.

$143.18 65,85% (12M)

P/E

110.80

2.36%

ROE

7.56%

P/BV

8.37

AZN - AstraZeneca

$156.59 --6,84% (12M)

P/E

18.71

2.06%

ROE

25.77%

P/BV

4.82

PFE - Pfizer

$27.48 7,47% (12M)

P/E

36.14

6.26%

ROE

5.07%

P/BV

1.83

BMY - Bristol-Myers Squibb

$60.33 39,02% (12M)

P/E

13.14

4.20%

ROE

41.59%

P/BV

5.46

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$888.29 20,83% (12 M)

P/L

22.96

0.38%

ROE

-118.84%

P/VP

-27.29

CAH - Cardinal Health

$226.17 47,96% (12 M)

P/L

30.94

0.91%

ROE

-62.92%

P/VP

-19.47

ABBV - AbbVie

$259.97 14,69% (12 M)

P/L

72.88

2.63%

ROE

-106.44%

P/VP

-77.57

MRK - Merck & Co.

$143.18 65,85% (12 M)

P/L

110.80

2.36%

ROE

7.56%

P/VP

8.37

AZN - AstraZeneca

$156.59 --6,84% (12 M)

P/L

18.71

2.06%

ROE

25.77%

P/VP

4.82

PFE - Pfizer

$27.48 7,47% (12 M)

P/L

36.14

6.26%

ROE

5.07%

P/VP

1.83

BMY - Bristol-Myers Squibb

$60.33 39,02% (12 M)

P/L

13.14

4.20%

ROE

41.59%

P/VP

5.46

Frequently Asked Questions

What is the price of Madrigal Pharmaceuticals (MDGL) today?

The current price of Madrigal Pharmaceuticals (MDGL) is $495.49. The stock began the year trading around $582.34 and is currently priced at $495.49. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Madrigal Pharmaceuticals (MDGL) pay dividends?

Madrigal Pharmaceuticals (MDGL) did not pay dividends over the past year.

Is Madrigal Pharmaceuticals (MDGL) a good investment?

Madrigal Pharmaceuticals (MDGL) is currently trading at $495.49 with a P/E ratio of -44.42. This represents a -2,979% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 11.85%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Madrigal Pharmaceuticals (MDGL) stock?

You can buy Madrigal Pharmaceuticals (MDGL) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol MDGL and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Madrigal Pharmaceuticals (MDGL) yield today?

Over the past month, Madrigal Pharmaceuticals (MDGL) has returned -9.22% — 11.85% over the past year, and 530.23% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Madrigal Pharmaceuticals (MDGL) today at the current price of $495.49 your total investment would be $49,549.00.

Based on historical performance, the investment would have grown to approximately:

$55,420.56 after 1 year
$312,272.66 after 5 years
$1,507,122.02 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

MDGL

Madrigal Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment MDGL

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING MDGL WITH OTHER STOCK

ABOUT Madrigal Pharmaceuticals

Madrigal Pharmaceuticals Inc.

United States

15 years

2007

42

PROFIT X PRICE MDGL

Financial Results MDGL

MDGL cash flow

Asset, Revenue and Profit Growth - MDGL

MDGL balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions